Patents by Inventor The Cleveland Clinic Foundation
The Cleveland Clinic Foundation has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130211852Abstract: A method includes determining team participant members for one or more wellness teams. The method includes aggregating participant medical data for each of the one or more wellness teams from one or more networked physiologic stations configured to receive the medical data. The method includes analyzing the medical data to determine wellness information for the one or more wellness teams associated with the aggregated participant medical data. The method can be operated on a system where the system includes at least one physiologic station to generate participant medical information from a plurality of participants. This can include an identification component to facilitate trust in collected data. A storage medium collects the medical information over a network from the plurality of participants and an analyzer determines group wellness information from the collected medical information.Type: ApplicationFiled: February 14, 2013Publication date: August 15, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130211379Abstract: A catheter assembly comprises a catheter including a catheter wall and a lumen extending lengthwise of the wall. The wall has inner and outer surfaces. The wall includes plural openings that extend through the wall and communicate with the lumen. An elongated hollow needle includes a proximal end portion and a distal end portion. The needle is movable in the lumen to move the distal end portion between the openings. The distal end portion is directed radially outward so as to extend into an adjacent opening. The distal end portion has a configuration that stores potential energy when in the lumen. The potential energy is converted to kinetic energy to produce movement of the proximal end portion as the distal end portion moves from the inner surface of the catheter wall across an edge of an opening. The movement of the proximal end portion is haptically perceptible.Type: ApplicationFiled: February 15, 2013Publication date: August 15, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130172953Abstract: Methods of treating acute heart failure in a patient in need thereof. Methods include inserting a therapy delivery device into a pulmonary artery of the patient and applying a therapy signal to autonomic cardiopulmonary fibers surrounding the pulmonary artery. The therapy signal affects heart contractility more than heart rate. Specifically, the application of the therapy signal increases heart contractility and treats the acute heart failure in the patient. The therapy signal can include electrical or chemical modulation.Type: ApplicationFiled: October 18, 2012Publication date: July 4, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130172898Abstract: An apparatus for transferring location and/or trajectory information from a reference surface to a patient tissue surface for guiding placement of a landmark includes a landmark guiding structure. At least two locating feet are provided, each being laterally spaced from, and indirectly connected to, the landmark guiding structure. A holdaway structure is connected to each locating foot and to the landmark guiding structure. The landmark guiding structure is placed in desired location and/or a desired trajectory with respect to the reference surface. Each locating foot is adjusted into guiding contact with a particular portion of the reference surface. Each locating foot is maintained in the guiding contact position, and the apparatus is placed with each locating foot in guiding contact with a particular portion of the patient tissue surface. A method of transferring location and/or trajectory information from a reference surface to a patient tissue surface is also disclosed.Type: ApplicationFiled: January 3, 2013Publication date: July 4, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130173306Abstract: A computer-implemented method can include acquiring data from at least one data source, the acquired data including health data for a patient. The acquired data can be transformed into episode model data according to a context-specific data model and the episode model data can be stored in a database. The method also includes generating at least one inverted index document for at least a portion of an episode for the patient based on the episode model data.Type: ApplicationFiled: December 12, 2012Publication date: July 4, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130172984Abstract: The present embodiments provide a stent graft having a tubular configuration defining a lumen therethrough, the stent graft having a proximal section and a distal section. A folded section is positioned between the proximal section and the distal section. The folded section includes a first fold directed toward the distal end and engaged with the proximal section and a second fold directed toward the proximal end and engaged with the distal section. A valve arrangement is positioned in at least one of the first and second folds providing access from an exterior of the graft to the interior of the stent graft for insertion of an additional device.Type: ApplicationFiled: December 20, 2012Publication date: July 4, 2013Applicant: CLEVELAND CLINIC FOUNDATIONInventor: CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130165871Abstract: A method of increasing blood flow through an obstructed blood vessel includes providing an expandable member substantially made of a mesh having a plurality of interstices. The expandable member is inserted into the blood vessel, positioned within the blood vessel with the proximal member end upstream of the distal member end and the member body located radially adjacent at least a portion of an obstruction, and expanded to bring at least a portion of the member body into contact with the obstruction. An outward radial force is exerted on the obstruction to dislodge at least one fragment from the obstruction and to enhance blood flow through the blood vessel past the obstruction. The at least one fragment is passed through at least one interstice of the member body in the radial direction, and is selectively retained within the expandable member.Type: ApplicationFiled: November 8, 2012Publication date: June 27, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130150975Abstract: A joint prosthesis system, specifically a shoulder prosthesis, for shoulder replacement, revision and repair. The implants provide fixation into the best bone available to a surgeon. The implants are used in a superior-inferior and anterior-posterior construct forming a type of cross or X-shape. The implants allow for interchangeability of the articulating component as well as rotational orientation. The systems will allow for augments to accommodate bone loss. The implants may allow for additional security using screws or anchors inserted into the scapula.Type: ApplicationFiled: December 7, 2012Publication date: June 13, 2013Applicants: IMDS CORPORATION, CLEVELAND CLINIC FOUNDATIONInventors: Cleveland Clinic Foundation, IMDS Corporation
-
Publication number: 20130144270Abstract: A device for clearing obstructions from a medical tube, such as a chest tube, is disclosed in various embodiments. The device features a clearance member in the form of a loop. The loop desirably has a diameter that substantially corresponds to the inner diameter of the medical tube. Also desirably, the loop presents a substantially unobstructed pathway therethrough for the flow of material from a location in the medical tube distal to the loop to a location in the medical tube proximal to the loop regardless whether the clearance member is being translated or is at rest in the medical tube. Methods of utilizing such a device are also disclosed.Type: ApplicationFiled: January 24, 2013Publication date: June 6, 2013Applicants: THE CLEVELAND CLINIC FOUNDATION, CLEAR CATHETER SYSTEMS, INC.Inventors: Clear Catheter Systems, Inc., The Cleveland Clinic Foundation
-
Publication number: 20130138400Abstract: Systems and methods are provided for predicting the results of a therapeutic intervention to an eye. An imaging system is configured to provide image data representing at least a portion of the eye of the patient. An input device is configured to permit a user to design a proposed therapeutic intervention for the eye of the patient. A finite element modeling component is configured to generate a finite element model representing the condition of the eye of the patient after the proposed therapeutic intervention according to the image data, the proposed therapeutic intervention, and at least one biomechanical property of tissue comprising the eye. The generated model is constructed as to have no a priori restraints on the motion of the corneal limbus. A display is configured to display the generated model to the user.Type: ApplicationFiled: December 31, 2012Publication date: May 30, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130131703Abstract: A method of increasing blood flow through an obstructed blood vessel includes providing an expandable member substantially made of a mesh having a plurality of interstices. The expandable member is inserted into the blood vessel, positioned within the blood vessel with the proximal member end upstream of the distal member end and the member body located radially adjacent at least a portion of an obstruction, and expanded to bring at least a portion of the member body into contact with the obstruction. An outward radial force is exerted on the obstruction to dislodge at least one fragment from the obstruction and to enhance blood flow through the blood vessel past the obstruction. The at least one fragment is passed through at least one interstice of the member body in the radial direction, and is selectively retained within the expandable member.Type: ApplicationFiled: January 23, 2013Publication date: May 23, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130132117Abstract: Systems and methods are disclosed for graphical-based management and documentation of longitudinal care episodes. As one example, a system to manage a longitudinal care episode for a patient can include a patient data aggregator, executable by a processor, to provide context data for the patient, at least a portion of the context data including patient data associated with multiple phases of the longitudinal care episode. A tool manager can translate user interactions with an associated graphical user interface (GUI) into corresponding discrete concepts. The corresponding discrete concepts can be stored in memory as part of longitudinal episode data for the patient, the longitudinal episode data being generated based on the context data and in response to user interactions with the GUI to facilitate documentation and management of the longitudinal care episode.Type: ApplicationFiled: November 16, 2012Publication date: May 23, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130123631Abstract: A system and method is provided for using backscattered data and known parameters to characterize vascular tissue. IVUS data is transmitted to a computing device and used to create an IVUS image. The blood vessel is then cross-sectioned and used to identify its tissue type and to create a corresponding image (i.e., histology image). A region of interest (ROI) is then identified on the histology image. The computing device identifies a corresponding region on the IVUS image. After the corresponding region is identified, the IVUS data that corresponds to this region is identified. Signal processing is then performed and at least one parameter is identified. The identified parameter and the tissue type is stored in a database. In another embodiment of the present invention, the characterization application is adapted to use the parameters stored in the database to identify a tissue type or a characterization thereof.Type: ApplicationFiled: October 4, 2012Publication date: May 16, 2013Applicant: The Cleveland Clinic FoundationInventor: The Cleveland Clinic Foundation
-
Publication number: 20130116799Abstract: A biocompatible tissue graft includes a first layer of a bioremodelable collageneous material, a second layer of biocompatible synthetic or natural remodelable or substantially remodelable material attached to the first layer; and at least one fiber that is stitched in a reinforcing pattern in the first layer and/or second layer to mitigate tearing and/or improve fixation retention of the graft, and substantially maintain the improved properties while one or more of the layers is remodeling.Type: ApplicationFiled: December 27, 2012Publication date: May 9, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130102536Abstract: A method of promoting hair growth of a subject includes administering to follicle cells of the subject a therapeutically effective amount of a TLR2 agonist that promotes TLR2 activation and hair growth of the subject.Type: ApplicationFiled: December 10, 2012Publication date: April 25, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130096891Abstract: This disclosure relates generally to systems and methods for estimating a volume of tissue directly influenced (VTDI) by optogenetic stimulation. The systems and methods can also enable a user to quantitatively predict the spread of stimulation (e.g., action potential) resulting from optical stimulation in a patient's tissue.Type: ApplicationFiled: October 12, 2012Publication date: April 18, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130079870Abstract: An endoluminal prosthesis may include a tubular main graft body including a sidewall and proximal and distal ends. A first stent may be positioned near the proximal end of the main graft body. A second stent may be positioned adjacent to and distal of the first stent. An opening in the sidewall may be positioned longitudinally between a peak of the first stent and a valley of the second stent. A tubular branch may be disposed in the opening. The branch may include first and second end openings. The branch may be flexibly orientable between a retrograde configuration in which the first end opening is oriented toward the distal end and the second end opening is oriented toward the proximal end and an antegrade configuration in which the first end opening is oriented toward the proximal end and the second end opening is oriented toward the distal end.Type: ApplicationFiled: September 25, 2012Publication date: March 28, 2013Applicants: The Cleveland Clinic Foundation, Cook Medical Technologies LLCInventors: Cook Medical Technologies LLC, The Cleveland Clinic Foundation
-
Publication number: 20130066347Abstract: A method of increasing blood flow through an obstructed blood vessel includes providing an expandable member substantially made of a mesh having a plurality of interstices. The expandable member is inserted into the blood vessel, positioned within the blood vessel with the proximal member end upstream of the distal member end and the member body located radially adjacent at least a portion of an obstruction, and expanded to bring at least a portion of the member body into contact with the obstruction. An outward radial force is exerted on the obstruction to dislodge at least one fragment from the obstruction and to enhance blood flow through the blood vessel past the obstruction. The at least one fragment is passed through at least one interstice of the member body in the radial direction, and is selectively retained within the expandable member.Type: ApplicationFiled: November 8, 2012Publication date: March 14, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: The Cleveland Clinic Foundation
-
Publication number: 20130066348Abstract: A method of increasing blood flow through an obstructed blood vessel includes providing an expandable member substantially made of a mesh having a plurality of interstices. The expandable member is inserted into the blood vessel, positioned within the blood vessel with the proximal member end upstream of the distal member end and the member body located radially adjacent at least a portion of an obstruction, and expanded to bring at least a portion of the member body into contact with the obstruction. An outward radial force is exerted on the obstruction to dislodge at least one fragment from the obstruction and to enhance blood flow through the blood vessel past the obstruction. The at least one fragment is passed through at least one interstice of the member body in the radial direction, and is selectively retained within the expandable member.Type: ApplicationFiled: November 8, 2012Publication date: March 14, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION
-
Publication number: 20130060227Abstract: A method is provided for delivering at least one therapeutic agent to an ocular tissue of a subject. The method includes providing an apparatus including at least one electrode, a medicament layer including at least one therapeutic agent, an electrical signal source, and logic configured to control the electrical signal source. The at least one electrode has oppositely disposed first and second dome-shaped major surfaces. The medicament layer is disposed on at least a portion of the second major surface. The electrical signal source is electrically connected to the at least one electrode. At least one portion of the first major surface is placed into contact with the ocular tissue so that the at least one portion substantially conforms to the contour of the ocular tissue. The electrical signal source provides a signal having certain characteristics to motivate the at least one therapeutic agent into the ocular tissue.Type: ApplicationFiled: November 2, 2012Publication date: March 7, 2013Applicant: THE CLEVELAND CLINIC FOUNDATIONInventor: THE CLEVELAND CLINIC FOUNDATION